Iovance Biotherapeutics, Inc.
IOVA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001425205
No open-market purchases or sales by Iovance Biotherapeutics, Inc. insiders were filed in the last 90 days; 293 institutions reported holding it in 13F filings for Q2 2026, worth $1.19B in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Iovance Biotherapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 255
- −45 vs. Q1 2025
- Shares held
- 220.3M
- −19.4M (−8.1%) vs. Q1 2025
- Total value
- $379.3M
- −$419.4M (−52.5%) vs. Q1 2025
- New holders
- 39
- 94 more added
- Sold out
- 84
- 72 more reduced
3 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IOVA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 293 | $1.19B |
| Q1 2026 | 286 | $943.8M |
| Q4 2025 | 263 | $713.7M |
| Q3 2025 | 253 | $462.3M |
| Q2 2025 | 255 | $379.3M |
| Q1 2025 | 303 | $798.9M |
| Q4 2024 | 302 | $1.79B |
| Q3 2024 | 286 | $2.21B |
| Q2 2024 | 295 | $1.86B |
| Q1 2024 | 273 | $3.22B |
| Q4 2023 | 236 | $1.69B |
| Q3 2023 | 228 | $970.0M |
| Q2 2023 | 219 | $1.44B |
| Q1 2023 | 230 | $1.25B |
| Q4 2022 | 218 | $1.11B |
| Q3 2022 | 242 | $1.48B |
| Q2 2022 | 238 | $1.75B |
| Q1 2022 | 248 | $2.60B |
| Q4 2021 | 246 | $2.96B |
| Q3 2021 | 244 | $3.88B |
| Q2 2021 | 234 | $4.22B |
| Q1 2021 | 252 | $4.98B |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Iovance Biotherapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| LPL Financial LLC | 484,327 | $833.0K | 0.00% | +107,931+28.7% | Added |
| Hennion & Walsh Asset Management, Inc. | 499,252 | $858.7K | 0.03% | +132,477+36.1% | Added |
| Swiss National Bank | 501,156 | $862.0K | 0.00% | +87,800+21.2% | Added |
| Voleon Capital Management LP | 509,668 | $876.6K | 0.05% | +509,668 | New |
| Standard Life Aberdeen plc | 516,289 | $888.0K | 0.00% | +384,489+291.7% | Added |
| Group One Trading, L.P. | 553,468 | $952.0K | 0.03% | +77,667+16.3% | Added |
| Woodline Partners LP | 567,680 | $976.4K | 0.01% | +765+0.1% | Added |
| Quinn Opportunity Partners LLC | 614,200 | $1.06M | 0.09% | +614,200 | New |
| Deutsche Bank AG | 620,446 | $1.07M | 0.00% | −64,700−9.4% | Reduced |
| Rhenman & Partners Asset Management AB | 647,827 | $1.11M | 0.14% | 00.0% | Unchanged |
| Invesco Ltd. | 653,949 | $1.12M | 0.00% | +319,692+95.6% | Added |
| UBS Asset Management Americas Inc | 657,209 | $1.13M | 0.00% | −5,120,135−88.6% | Reduced |
| Voss Capital, LLC | 672,570 | $1.16M | 0.08% | +672,570 | New |
| QVT Financial LP | 678,564 | $1.17M | 0.16% | 00.0% | Unchanged |
| CM Management, LLC | 700,000 | $1.20M | 1.10% | +200,000+40.0% | Added |
| Citigroup Inc | 714,851 | $1.23M | 0.00% | +176,539+32.8% | Added |
| Nuveen, LLC | 778,750 | $1.34M | 0.00% | −107,988−12.2% | Reduced |
| Bank of New York Mellon Corp | 780,627 | $1.34M | 0.00% | −137,583−15.0% | Reduced |
| Squarepoint Ops LLC | 856,569 | $1.47M | 0.00% | +458,540+115.2% | Added |
| Barclays PLC | 884,340 | $1.52M | 0.00% | +313,504+54.9% | Added |
| Schroder Investment Management Group | 897,354 | $1.54M | 0.00% | +394,791+78.6% | Added |
| Wells Fargo & Company | 1,074,250 | $1.85M | 0.00% | +215,680+25.1% | Added |
| JPMorgan Chase & Co | 1,242,871 | $2.14M | 0.00% | −37,379−2.9% | Reduced |
| C WorldWide Group Holding A/S | 1,260,000 | $2.17M | 0.03% | 00.0% | Unchanged |
| B Group, Inc. | 1,500,000 | $2.58M | 2.23% | 00.0% | Unchanged |
| Balyasny Asset Management LLC | 1,507,782 | $2.59M | 0.01% | +1,297,841+618.2% | Added |
| Rice Hall James & Associates, LLC | 1,591,575 | $2.74M | 0.15% | +22,363+1.4% | Added |
| UBS Group AG | 1,779,412 | $3.06M | 0.00% | −717,337−28.7% | Reduced |
| Tang Capital Management LLC | 1,800,000 | $3.10M | 0.16% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 1,916,486 | $3.30M | 0.00% | +68,745+3.7% | Added |
| Jane Street Group, LLC | 2,007,571 | $3.45M | 0.01% | +1,886,481+1,557.9% | Added |
| Susquehanna International Group, LLP | 2,071,472 | $3.56M | 0.01% | +269,279+14.9% | Added |
| Price T Rowe Associates Inc | 2,114,190 | $3.64M | 0.00% | −289,890−12.1% | Reduced |
| Northern Trust Corp | 2,119,787 | $3.65M | 0.00% | −223,776−9.5% | Reduced |
| Two Sigma Advisers, LP | 2,334,900 | $4.02M | 0.01% | +2,334,900 | New |
| Orion Investment Co | 2,338,563 | $4.02M | 1.43% | +1,161,710+98.7% | Added |
| Royal Bank of Canada | 2,379,088 | $4.09M | 0.00% | +1,856,201+355.0% | Added |
| Dimensional Fund Advisors LP | 2,928,736 | $5.04M | 0.00% | −577,372−16.5% | Reduced |
| Soleus Capital Management, L.P. | 3,261,707 | $5.61M | 0.39% | −4,523,293−58.1% | Reduced |
| Palo Alto Investors LP | 3,429,329 | $5.90M | 1.25% | +218,015+6.8% | Added |
| Bank of America Corp | 4,029,568 | $6.93M | 0.00% | +1,012,383+33.6% | Added |
| Citadel Advisors LLC | 4,113,588 | $7.08M | 0.01% | +2,380,785+137.4% | Added |
| Principal Financial Group Inc | 4,601,441 | $7.91M | 0.00% | −92,681−2.0% | Reduced |
| Two Sigma Investments, LP | 4,633,451 | $7.97M | 0.01% | +4,236,457+1,067.1% | Added |
| Goldman Sachs Group Inc | 4,749,876 | $8.17M | 0.00% | −822,026−14.8% | Reduced |
| Renaissance Technologies LLC | 4,887,200 | $8.41M | 0.01% | +1,375,800+39.2% | Added |
| Geode Capital Management, LLC | 6,189,058 | $10.6M | 0.00% | +220,760+3.7% | Added |
| Morgan Stanley | 6,450,933 | $11.1M | 0.00% | +2,432,559+60.5% | Added |
| Invenomic Capital Management LP | 8,294,663 | $14.3M | 0.81% | +2,804,864+51.1% | Added |
| Millennium Management LLC | 9,330,223 | $16.0M | 0.01% | +9,171,900+5,793.2% | Added |
| State Street Corp | 9,890,525 | $17.0M | 0.00% | −1,150,797−10.4% | Reduced |
| Long Focus Capital Management, LLC | 11,820,000 | $20.3M | 1.31% | +2,569,945+27.8% | Added |
| BlackRock, Inc. | 23,236,812 | $40.0M | 0.00% | −1,077,766−4.4% | Reduced |
| Vanguard Group Inc | 25,076,472 | $43.1M | 0.00% | −2,701,306−9.7% | Reduced |
| MHR Fund Management LLC | 28,967,103 | $49.8M | 5.53% | +4,550,000+18.6% | Added |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −12,711,788−100.0% | Sold out |
| Hood River Capital Management LLC | 0 | $0 | 0.00% | −9,216,040−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −4,791,235−100.0% | Sold out |
| Artisan Partners Limited Partnership | 0 | $0 | 0.00% | −4,407,713−100.0% | Sold out |
| MPM Oncology Impact Management LP | 0 | $0 | 0.00% | −2,708,582−100.0% | Sold out |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −2,400,000−100.0% | Sold out |
| Apis Capital Advisors, LLC | 0 | $0 | 0.00% | −1,277,000−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −1,258,561−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −1,170,745−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −972,689−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −280,882−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −260,148−100.0% | Sold out |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −254,879−100.0% | Sold out |
| NFJ Investment Group, LLC | 0 | $0 | 0.00% | −187,342−100.0% | Sold out |
| RMB Capital Management, LLC | 0 | $0 | 0.00% | −157,696−100.0% | Sold out |
| Skandinaviska Enskilda Banken AB (publ) | 0 | $0 | 0.00% | −155,684−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −134,765−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −134,535−100.0% | Sold out |
| PFM Health Sciences, LP | 0 | $0 | 0.00% | −132,152−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −122,930−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −119,008−100.0% | Sold out |
| Sit Investment Associates Inc | 0 | $0 | 0.00% | −109,325−100.0% | Sold out |
| Nebula Research & Development LLC | 0 | $0 | 0.00% | −94,338−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −87,129−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −84,397−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −79,442−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −69,881−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −69,000−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −59,321−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Shay Capital LLC | 0 | $0 | 0.00% | −42,900−100.0% | Sold out |
| Pale Fire Capital SE | 0 | $0 | 0.00% | −42,897−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −42,527−100.0% | Sold out |
| Henshaw Capital LLC | 0 | $0 | 0.00% | −41,780−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −37,758−100.0% | Sold out |
| Clear Harbor Asset Management, LLC | 0 | $0 | 0.00% | −35,250−100.0% | Sold out |
| Exchange Traded Concepts, LLC | 0 | $0 | 0.00% | −34,061−100.0% | Sold out |
| Virginia Retirement Systems Et Al | 0 | $0 | 0.00% | −31,000−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −28,010−100.0% | Sold out |
| Janney Montgomery Scott LLC | 0 | $0 | 0.00% | −25,755−100.0% | Sold out |
| JustInvest LLC | 0 | $0 | 0.00% | −23,730−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −23,000−100.0% | Sold out |
| SIH Partners, LLLP | 0 | $0 | 0.00% | −20,637−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −20,300−100.0% | Sold out |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |